Meropenem clinical pharmacology: Revision history

5 January 2014

• curprev 22:3922:39, 5 January 2014‎ Gerald Chi talk contribs‎ m 4,785 bytes +28‎ No edit summary

26 December 2013

• curprev 01:3201:32, 26 December 2013‎ Gerald Chi talk contribs‎ m 4,757 bytes −22‎ →‎Distribution
• curprev 01:3201:32, 26 December 2013‎ Gerald Chi talk contribs‎ m 4,779 bytes −2‎ No edit summary

23 December 2013

• curprev 00:3200:32, 23 December 2013‎ Gerald Chi talk contribs‎ m 4,781 bytes −3‎ No edit summary
• curprev 00:3100:31, 23 December 2013‎ Gerald Chi talk contribs‎ m 4,784 bytes +1,080‎ →‎Clinical Pharmacology

21 December 2013

• curprev 13:3013:30, 21 December 2013‎ Gerald Chi talk contribs‎ m 3,704 bytes 0‎ No edit summary

20 December 2013

• curprev 21:4821:48, 20 December 2013‎ ShiSheng talk contribs‎ 3,704 bytes +330‎ No edit summary
• curprev 21:4221:42, 20 December 2013‎ ShiSheng talk contribs‎ 3,374 bytes +67‎ No edit summary

19 December 2013

• curprev 20:3120:31, 19 December 2013‎ ShiSheng talk contribs‎ 3,307 bytes +3,307‎ Created page with "At the end of a 30-minute intravenous infusion of a single dose of MERREM I.V. in normal volunteers, mean peak plasma concentrations are approximately 23 µg/mL (range 14-26..."